INS and type 2 diabetes mellitus: The above medicines have made tremendous contributions to the treatment of type II diabetes, where they have been found to mainly achieve therapeutic effects by promoting insulin secretion or absorption in patients with type II diabetes, and indirectly control type II diabetes by protecting and enhancing the effect of endogenous incretin [12].